The world’s leading healthcare companies partner with Water Street to divest non-core businesses that we build into successful, standalone companies. They also acquire companies from us that support their long-term strategic goals. Hear what executives from the world's leading healthcare corporations have to say about why they selected Water Street as their partner:

“We are eager to combine resources with PLUS Diagnostics, which will allow us to expand our commitment to our clients and our patients by partnering with a substantial and well-respected pathology institution.  PLUS shares our vision and commitment to deliver personalized customer service and the highest quality diagnostic and prognostic information.  We expect to be able to extend our world-class pathology services to a broader base of physicians and patients thanks to this transaction.”

Miraca Life Sciences acquired PLUS, an anatomic pathology company, from Water Street in 2013 to become the largest indepdent pathology laboratory company in the United States.

“We are excited to enter a new attractive market segment with an already established sales infrastructure focused entirely on the dental community. We believe that this market segment has similar characteristics to the dermatology, podiatry and ophthalmology markets and should offer us the opportunity to cross-sell some of our current products, most notably our new topical prescription cold sore medication, Xerese. We believe the OraPharma business is a new growth platform from which to build additional opportunities in the future.”

Valeant acquired OraPharma, Water Street’s specialty pharmaceutical company specializing in dental and oral healthcare, in 2012.

“The acquisition of PDC provides an anchor position for Brady in the attractive healthcare identification space and fits well with our mission to identify and protect premises, products and people.  The company’s management expertise, large customer base, strong channels to market, and broad product offering have made PDC the domestic market leader in healthcare identification.  The strengths of PDC, together with Brady’s healthcare identification product offering, deep materials and printer expertise, and our global footprint, make this a very attractive business combination.”

Brady Corporation acquired PDC, Water Street’s patient safety products company, in 2012 to further its presence in the healthcare industry.

“We have created considerable value by partnering with Water Street to make CareCentrix a standalone company. Water Street’s focus on health care and their particular expertise in payer services will benefit CareCentrix tremendously. It is for this very reason that we decided to maintain a 31 percent ownership stake in CareCentrix. We think the business and its employees will thrive under Water Street’s strategic direction, and we are excited to continue to participate in that success through our equity investment. We look forward to a long and prosperous partnership with Water Street.”

Gentiva partnered with Water Street to divest its CareCentrix business unit in 2008. Water Street transformed CareCentrix into the nation’s leading home health benefits management company.

“Physiotherapy Associates has been an important contributor to Stryker’s growth. As we focus our efforts on the medical technology market, we believe that Physiotherapy will be even more successful under the ownership of a party focused on healthcare services. We are pleased that Water Street intends to continue Physiotherapy’s legacy of outstanding patient care. We have confidence that Physiotherapy’s employees and patients will benefit from Water Street’s leadership, experience and industry knowledge.”

Stryker collaborated with Water Street in 2007 to divest its outpatient physical therapy business, Physiotherapy Associates. Water Street has transformed Physiotherapy Associates into the nation’s foremost provider of outpatient rehabilitation services.

“When we divested one of our healthcare businesses to Water Street, I was struck by their unique business approach. They were very knowledgeable, professional and more importantly, committed to doing the right thing for our employees, partners and customers. Because I was so impressed with their team and how they managed the transaction, I ultimately decided to join Water Street when I retired from Johnson & Johnson.

Johnson & Johnson collaborated with the Water Street team to divest its Jelco I.V. Catheter business in 2003. We simultaneously merged it with another company to create the market leader in fluid and drug delivery in critical care.

“The principals of Water Street were terrific to work with when we decided to divest Sorvall products. DuPont has worked with many private equity firms and the Sorvall transaction stands out as the smoothest and most satisfying, given the success of the business and our employees. In retrospect, the only thing I would have changed was to keep an ownership stake in the business!”

DuPont partnered with the Water Street team in 1996 to divest its Sorvall Laboratory Instruments business. We transformed Sorvall into a global leader in products and services to the laboratory life sciences and drug discovery markets.

“This acquisition affirms our position as the worldwide market leader in neurology. Approximately two-thirds of Alpine Biomed’s revenue is from outside the United States, and Alpine Biomed is the market leader in electromyography diagnostics, or EMG, in Europe with its well established Keypoint product line. In addition, we believe this acquisition signals that our business model that combines internal growth and accretive acquisitions is back on track.”

Natus Medical acquired Water Street’s specialty neurodiagnostic device business, Alpine Biomed, in 2009.

“Sierra Scientific is a strong, well managed company respected by the GI community for its cutting-edge products, which deliver reliable performance. This acquisition strengthens Given Imaging’s position as the global leader in the gastroesophageal diagnostic market. With manometry, impedance, catheter pH and Bravo wireless pH products, we advance our vision of providing total world-class solutions to our GI customers’ evolving product needs. From a financial standpoint, acquiring Sierra will increase our revenue base, and ultimately profitability. It enables us to diversify our product and geographic revenues through access to additional best-in-class products, people, and manufacturing assets. We plan to offer our full product portfolio to our expanded customer base to drive broader use of all of our products.”

Given Imaging purchased Water Street’s specialty gastrodiagnostic device company, Sierra Scientific Instruments, in 2010.